Sex: F
Vaccine: MMR, VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Measles antibody positive, Mumps antibody test positive
Clinical narrative: She received SHINGRIX, an unspeciifed time after receiving "MMR", she experienced an injection site reaction characterized by redness, swelling, and the area being warm to touch.; She received SHINGRIX, an unspeciifed time after receiving "MMR", she experienced an injection site reaction characterized by redness, swelling, and the area being warm to touch.; She received SHINGRIX, an unspeciifed time after receiving "MMR", she experienced an injection site reaction characterized by redness, swelling, and the area being warm to touch.; Unspecified thyroid level drawn on 01-MAR-2024 and her level was a "little over".; This spontaneous report has been received from the patient referring to herself, a 72-year-old female patient.  The patient's medical history and concurrent conditions were not reported. It was reported that since unspecified date (reported as "for the past five years"), she had been on an unspecified thyroid medication, however, she did not provide the reason for the start of the thyroid medication.   On an unspecified date in 2014, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, administered for prophylaxis (strength, dose, frequency, lot #, expiration date, route of administration and anatomical location were not provided); and with varicella zoster vaccine rge (cho) (SHINGRIX), (formulation, strength, dose, frequency, indication, lot #, expiration date, route of administration and anatomical location were not provided).  On an unspecified date, the patient experienced injection site reaction characterized by redness (vaccination site erythema), swelling (vaccination site swelling) and the area was too warm to touch (vaccination site warmth). Additionally, it was stated that on 01-MAR-2024, the patient recently had an unspecified thyroid level drawn which showed her levels "a little over" (thyroid hormones increased); thus, she was advised to take her unspecified thyroid medication four pills per day (on Monday, Wednesday and Friday), and three pills per day on the remaining days due to her thyroid level being a "little over". Before her dosage adjustment, she was taking three pills per day of the unspecified thyroid medication. It was unknown by the reporter if the patient sought medical attention or if any laboratory diagnostics or study procedures were performed. On 27-MAR-2024, she had titers drawn which revealed immunity to measles, mumps and rubella. The outcome of the events were not provided.  The action taken regarding thyroid hormones increased, vaccination site erythema, vaccination site swelling and vaccination site warmth with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection and varicella zoster vaccine rge (cho) (SHINGRIX) was not reported.   The causal relationship between all the event and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection and varicella zoster vaccine rge (cho) (SHINGRIX) was not reported.